about
Pharmacotherapy of vestibular and ocular motor disorders, including nystagmusVestibular paroxysmia: a treatable neurovascular cross-compression syndrome.Update on the pharmacotherapy of cerebellar and central vestibular disordersDeterminants for a Successful Sémont Maneuver: An In vitro Study with a Semicircular Canal Model.Which medication do I need to manage dizzy patients?N-acetyl-L-leucine accelerates vestibular compensation after unilateral labyrinthectomy by action in the cerebellum and thalamusCalretinin as a Marker for Premotor Neurons Involved in Upgaze in Human BrainstemThe effects of bilateral vestibular loss on hippocampal volume, neuronal number, and cell proliferation in rats.Vestibular function and quality of life in vestibular schwannoma: does size matter?Central oculomotor disturbances and nystagmus: a window into the brainstem and cerebellumOcular VEMPs indicate repositioning of otoconia to the utricle after successful liberatory maneuvers in benign paroxysmal positioning vertigoVestibular loss causes hippocampal atrophy and impaired spatial memory in humans.Spatial memory and hippocampal volume in humans with unilateral vestibular deafferentation.Long-term course of Menière's disease revisited.Presence of HSV-1 immediate early genes and clonally expanded T-cells with a memory effector phenotype in human trigeminal ganglia.The presence of lytic HSV-1 transcripts and clonally expanded T cells with a memory effector phenotype in human sensory ganglia.Semicircular canal, saccular and utricular function in patients with bilateral vestibulopathy: analysis based on etiologyThe human vertical translational vestibulo-ocular reflex. Normal and abnormal responses.The takeaway Frenzel goggles: a Fresnel-based device.Model approach to neurological variants of visuo-spatial neglect.Methylprednisolone, valacyclovir, or the combination for vestibular neuritis.The disturbance of gaze in progressive supranuclear palsy: implications for pathogenesisCharacterization of neuronal populations in the human trigeminal ganglion and their association with latent herpes simplex virus-1 infection.Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response.Central compensation of deviated subjective visual vertical in Wallenberg's syndrome.Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial.Pharmacological advances in the treatment of neuro-otological and eye movement disorders.Causative factors and epidemiology of bilateral vestibulopathy in 255 patients.Episodic ataxia type 2.Acetyl-DL-leucine improves gait variability in patients with cerebellar ataxia-a case series.Clinical evaluation of the bed cycling testThe treatment and natural course of peripheral and central vertigo.Fewer latent herpes simplex virus type 1 and cytotoxic T cells occur in the ophthalmic division than in the maxillary and mandibular divisions of the human trigeminal ganglion and nerve.Effects of acetyl-DL-leucine in patients with cerebellar ataxia: a case seriesMedical treatment of vestibular disorders.Diagnosis and treatment of vertigo and dizziness.Parallel ascending vestibular pathways: anatomical localization and functional specialization.Causative factors, epidemiology, and follow-up of bilateral vestibulopathy.Long-term course and relapses of vestibular and balance disorders.The linear vestibulo-ocular reflex, locomotion and falls in neurological disorders.
P50
Q24595123-BAC01150-8B58-4A54-84D2-3C6B8693EFE1Q26753114-E5250614-3E7E-4158-901F-51D9324724A9Q26753139-5CD54FB8-1968-4F5E-8471-7AF428A2D2C1Q27318109-BF04998B-BCD8-496C-BEA0-C58E8121F244Q28300141-F54FEE64-30D8-46A5-B144-2DBD969240F3Q28544952-BD527208-5AFA-442F-869F-E97AA9034040Q30395500-46B7859B-148F-4F8D-B364-70FC8BBAE1E7Q30469719-080F8829-16F2-45AD-88B9-3F7CDC4DFF2BQ30474080-1AB0C39E-1AB7-4664-AE8E-B25A2AB76095Q30475787-8DC617AD-BD68-4B4E-8404-BC3317E910AAQ30581475-C0E459BE-6801-4335-BD63-95ED4A2613CBQ31002918-369B213C-E2E0-4625-9517-B3AC47C6856AQ31107691-C26195B0-A0EA-46A1-87CA-F9AF33EF8211Q33158165-D186BDB1-450A-4C0D-99DD-EF0166885E46Q33296893-3C65D62E-22A3-4878-9D29-847F48A26E25Q33489001-EB3E1855-256C-4ED0-9934-8D8E4C49AA20Q33800588-E586AC98-C2F6-4A1D-AF26-C3C6229F403DQ33805399-A5986955-3062-4078-B720-A446FC3F2862Q34269007-183E9B99-9B26-42B6-A38E-639D0B8D04BAQ34297094-47465C83-4A91-491D-B360-84E9E0D85A27Q34335208-64653905-9BC1-4C31-A233-3E411B8E225FQ34435118-2F253E75-A142-4689-A463-FED042F3F085Q35075587-442E8C08-16E3-43EA-9836-8D74BC3F1A46Q35843276-C0BFA685-9D71-422E-973A-9587738F09A6Q36227475-2C1182D8-6C12-440E-8BEE-A83577059ADAQ36244782-1BF4A49C-65EB-475A-9DAF-A4ADB6BD60DDQ36369740-09F43F3B-BDF0-4C6B-A2E8-2C6CFA051770Q36773718-81D6556E-61F9-4EED-9C6A-60C4BB9836C9Q36774729-01AB7F27-C160-4455-AA7A-29CB929C84F3Q36790476-34B567F4-999B-4DF8-881D-CFF4847007E2Q36792415-782190EE-FE2C-4974-8681-47894E2DB03EQ37118909-993BC57B-D581-46A3-9D48-8CD802574FFDQ37145216-F3F0BB37-F01A-4514-8BDE-35F4D6691E53Q37299546-A3D589A3-4ED2-47F6-942C-95784CB59E6BQ37519697-CC1D0A7E-DDA5-4CC3-9AE5-6A040F8B7435Q37560632-997E8EE9-21BF-4866-8A85-BEACCDBBD2E1Q37567978-FCB0E55B-FB00-48AA-A216-BDCCF166E8F7Q37568010-5AA2A581-DA5D-4FBC-B2F1-DB4B5DE80177Q37677981-15ED3016-EE49-494B-81F4-4968D9A37A79Q37677985-332AC87F-B149-4F14-A121-D285981467BE
P50
name
Michael Strupp
@ast
Michael Strupp
@en
Michael Strupp
@es
Michael Strupp
@nl
type
label
Michael Strupp
@ast
Michael Strupp
@en
Michael Strupp
@es
Michael Strupp
@nl
prefLabel
Michael Strupp
@ast
Michael Strupp
@en
Michael Strupp
@es
Michael Strupp
@nl
P214
P214
P31
P735
P7859
lccn-n2005182247